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Extrinsic fibroblast growth factor (FGF) signal and intrinsic factors that determine the response of the signal-receiving blastomeres to FGF
regulate mesoderm patterning in embryos of the ascidian Halocynthia roretzi. To investigate how cells integrate information from extrinsic and
intrinsic inputs, we examined Brachyury (Hr-Bra) promoter activity in the early embryo. Hr-Bra, which encodes a key transcription factor for
notochord development, is expressed exclusively in notochord precursors in a manner dependent on the FGF-MEK-MAPK-Ets signaling pathway
and on the intrinsic factors Zic and FoxA. Reporter gene expression driven by the 900-bp upstream region of the Hr-Bra promoter was detected as
early as the 110-cell stage in notochord precursors by in situ hybridization with a LacZ probe. Deletion analysis combined with MEK inhibitor
treatment demonstrated that the −598/−499 region carries FGF-responsiveness. Electrophoretic mobility shift assay identified three Ets-binding
sites in this region that were required for promoter activity. Further deletion analysis conducted by injecting eggs with reporter constructs at higher
concentration suggested that the −398/−289 region also has enhancer activity, although ectopic reporter expression was detected in nerve cord and
endoderm precursors. The −398/−289 region has a Zic-binding site that was also essential for the enhancer activity. These results indicate that Ets-
and Zic-binding sites are critical for the initiation of Hr-Bra expression. In conclusion, information from both extrinsic and intrinsic factors is
integrated at the level of enhancer of the target gene by direct binding of the transcription factors to the enhancer region.
© 2007 Elsevier Inc. All rights reserved.Keywords: Ascidian embryo; Notochord; Embryonic induction; Brachyury; FGF; Ets; Zic; FoxAIntroduction
Embryonic induction plays crucial roles in animal development.
Various organisms utilize a limited variety of signalingmolecules for
intercellular communication. The same signals are used over and
over again in different cells at different stages, with different
biological outcomes depending on the spatial and temporal context.
This reflects the ‘responsiveness’ or ‘competence’ of the signal-
receiving cells. The inducing signals are secretory molecules, and
intrinsic factors within the signal-receiving cells determine the nature
of the response to extrinsic signal molecules. To understand animal
development, it is important to clarify how particular cell fates are
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doi:10.1016/j.ydbio.2007.03.034signal-receiving cells. In this study, we investigate this issue in the
case of notochord induction in ascidian embryos. The notochord is a
unique character shared by chordates. The notochord runs from
anterior to posterior in the center of the tail, and provides a supportive
structure for muscle-generated tail movement. Inductive interaction
is involved in notochord formation in various vertebrates (Gurdon,
1987), and in ascidians, as described below. Subsequently notochord
provides signals that organize its surrounding tissues in vertebrates
(Yamada et al., 1993).
In the ascidian embryo, cell fates in most embryonic cells are
invariantly restricted to give rise to a single cell type by the 110-
cell stage (Nishida, 1987). The ascidian tadpole larva has exactly
40 notochord cells, of which 32 are designated the primary
notochord, and 8, at the tip of the tail, as secondary notochord.
The primary notochord cells are derived from 8 anterior-vegetal
blastomeres of the 110-cell embryo, and the developmental fate
is restricted as early as the 64-cell stage. The secondary lineage is
restricted to 2 posterior-vegetal blastomeres at the 110-cell stage.
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have been well studied. Formation of notochord requires an
inductive signal that emanates from presumptive endoderm or
notochord blastomeres at the 32-cell stage (Nakatani and
Nishida, 1994). This signal is fibroblast growth factor (FGF9/
16/20, Nakatani et al., 1996; Shimauchi et al., 2001a; Imai et al.,
2002a). In the absence of the FGF signal, presumptive primary
notochord blastomeres (A7.3 and A7.7) give rise to nerve cord
(Minokawa et al., 2001; Nakatani et al., 1996). The FGF signal
activates the FGF receptor-Ras-MAPK signaling pathway, and
is transduced to activate Ets transcription factor (Nakatani and
Nishida, 1997; Kim and Nishida, 2001; Shimauchi et al., 2001b;
Imai et al., 2002a; Miya and Nishida, 2003).
Notochord induction requires not only activation of Ets by
external FGF signal, but also competence or responsiveness to the
signal within the notochord precursors (A6.2, A6.4). FGF9/16/20
induces the primary notochord in the anterior-vegetal blastomere at
the 32-cell stage, whereas the same FGF also induces mesenchyme
in the posterior-vegetal blastomere at the same stage (Kim et al.,
2000). The difference in responsiveness between anterior and
posterior blastomeres depends on maternal macho-1 mRNA,
which is localized to the posterior-vegetal egg cytoplasm. In ma-
cho-1-knockdown embryos, ectopic notochord is induced in the
posterior-vegetal half, and in macho-1-overexpressing embryos,
ectopic mesenchyme is induced in the anterior-vegetal half
(Kobayashi et al., 2003). On the other hand, notochord fate
acquisition by FGF-stimulated anterior-vegetal cells involves the
β-catenin downstream genes (zygotic FoxD and its downstream
gene Zic) (Imai et al., 2000; Imai et al., 2002b; Wada and Saiga,
2002). FoxA (formerlyHNF-3β) is also expressed in the notochord
precursor blastomeres, and is also important as an intrinsic
competence factor for notochord responsiveness (Shimauchi et
al., 1997, 2001a; Kumano et al., 2006). FGF9/16/20 is also
involved in brain induction. In this case, the intrinsic competence
factor is GATA (Bertrand et al., 2003).
The FGF signal and intrinsic transcription factors, such as Zic
and FoxA, have important roles in notochord induction.
However, it is unknown how cells integrate the external FGF
signal with intrinsic competence factors for the formation of
notochord. To approach this issue, we investigated the cis-
regulatory elements of the Brachyury gene, which encodes a key
factor for notochord formation. Brachyury is a T-box transcrip-
tion factor, and in ascidians the gene is exclusively expressed in
the presumptive notochord blastomeres (A7.3, A7.7) at the 64-
cell stage, immediately after notochord induction (Yasuo and
Satoh, 1994). Overexpression of Brachyury results in ectopic
notochord formation associated with expression of various
notochord-specific genes (Yasuo and Satoh, 1998; Takahashi et
al., 1999a; Hotta et al., 2000). It is possible that Brachyury is
directly regulated by notochord inductive processes.
The 5′ upstream promoter elements of Brachyury have been
analyzed in both Halocynthia roretzi (Hr-Bra) and Ciona
intestinalis (Ci-Bra). Hr-Bra augments its own transcription by
binding to a T-box-binding motif present in its own promoter
(Takahashi et al., 1999b). In the study, the expression of the
reporter was monitored at tailbud stage. This autoregulation
mechanism is likely involved in the maintenance of geneexpression at later stages, but cannot be critical for the initiation
of notochord-specific expression at the fate specification stage.
In Xenopus, Xbra and FGF constitute an autoregulatory loop
(Casey et al., 1998). However, in ascidians, Brachyury
expression is directly autoregulated by the Brachyury protein.
In Ciona, it has been shown that Ci-ZicL binds directly to the
Ci-Bra promoter and activates the transcription at late cleavage
stage (Yagi et al., 2004b). Since Ci-ZicL is expressed not only in
notochord precursor but also in muscle, mesenchyme, and nerve
cord precursors, the transcription of Ci-Bra has to be repressed in
non-notochord precursors. An ectopic repressor region has been
characterized in the Ci-Bra promoter (Corbo et al., 1997). The
Snail protein represses the ectopic muscle expression of the
reporter by direct binding (Fujiwara et al., 1998). In Halo-
cynthia, notochord formation is also experimentally repressed by
Snail misexpression (Kobayashi et al., 2003). However, no FGF-
signal-responsive element has ever been reported, although such
an element would be expected to be critical to drive notochord-
specific expression of the Brachyury gene.
In this study, we investigated how the information provided
by extracellular FGF and intrinsic factors is integrated to drive
the initial notochord-specific expression of Hr-Bra. Our results
reveal that direct activation by both Ets and Zic is required for
the initial expression of Hr-Bra, suggesting that information
from extrinsic and intrinsic inputs is directly integrated at the
promoter of the target gene.
Materials and methods
Animals, embryos, and MEK inhibitor treatment
H. roretzi was collected or purchased from fishermen near the Asamushi
Research Center for Marine Biology, Aomori, and the Otsuchi International
Coastal Research Center, Iwate, Japan. Naturally spawned eggs were fertilized
with non-self sperm and cultured at 12 °C. In some experiments, embryos were
treated with 2 μM MEK inhibitor (U0123, Promega) to inhibit FGF-MAPK
signaling (Kim and Nishida, 2001).
LacZ reporter constructs
Hr-Bra promoter and LacZ fusion constructs (Bra897; Fig. 1) were kindly
provided by Dr. H. Takahashi as starting materials (Takahashi et al., 1999b).
Bra897 was used as a PCR template for making 5′ deletion series. Deleted
fragments were amplified using KOD Plus Enzyme (Toyobo) with the primers
listed below (−798F to −198F and XhoI-66F) as forward primers and +112R as
the reverse primer. Additional sequences including XhoI or BamHI sites, added
at the 5′ end of the primers, are shown in lower case. PCR products were
digested with XhoI and BamHI and inserted into the same restriction enzyme
sites of the p46.21 lacZ vector.
−798F:gggctcgagAAGCAATTTGTCGAAACCTA
−698F:gggctcgagGGAGCACACATAGATATAAT
−598F:gggctcgagTATTCCCAATTTGTCATGCT
−499F:gggctcgagTGACGTCGATCGAAATTATT
−398F:gggctcgagTAGAAACATAATAAAACAAA
−198F:gggctcgagAACTTTGTTTACCGCATTCA
XhoI−66F:gggctcgagCCTGCAGTCAGTGAGAT
+112R:gggggatccATGAACTTTTTCAAAAAATTC
For making proximal deletions, Bra897 was amplified with the primers
shown below (−800R to − 300R) as forward primers and NheI-66F as the
reverse primer. Additional NheI sites at the 5′ end of the primers are shown in
Fig. 1. The 5′ upstream sequence of Hr-Bra. Arrows indicate nucleotide positions numbered from the transcription initiation site (+1). Black boxes indicate the
previously identified autoregulatory T-box-binding site and enhancer element (Takahashi et al., 1999b). Red underlines show probe sequences that were used in EMSA
(Figs. 4, 7, and 8). The broken underlines are putative binding sites (BS) for Fox and CREB proteins. Three EtsBSs (green boxes) and a ZicBS (purple ellipse) were
identified in this study.
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digested with DpnI. The undigested amplified fragments were further digested
with NheI and self-ligated.
−800R:ggggctagcACGATCAAAAAGATAT
−700R:ggggctagcTGCATATGTAAAAATA
−600R:ggggctagcATTGGACCAAAATGATTT
−500R:ggggctagcACGCAGCGTGATGTTGATTG
−400R:ggggctagcTATGTTTGTTCAGTGCAATT
−300R:ggggctagcAAAATCGGGCTCAGTTCGCC
NheI−66F:ggggctagcCCTGCAGTCAGTGAGAT
To make base-substitution mutations by PCR, we used Bra598 as the PCR
template. To mutate Ets-binding sites (EtsBS) we first prepared
Bra598EtsBS1m, in which EtsBS1 was mutated, using the same method as
for the Bra598 construct (see above), but using forward primer EtsBS1mF
(shown below) instead of the −598F primer. Bra598EtsBS1,2,3m construct was
then prepared from the Bra598EtsBS1m by amplifying fragments containing
mutations in EtsBS2 and EtsBS3 with EtsBS2mR and EtsBS3mF primers. After
removal of the template DNA by digestion with DpnI and phosphorylation with
T4 polynucleotide kinase (Toyobo), the amplified fragment was self-ligated.
Bra598ZicBSm, which has a mutated ZicBS and Bra596FoxABS1,2m, with
two mutated putative FoxBSs, were prepared using the following primers
(ZicBSmF and ZicBSmR for Bra598ZicBSm; FoxABS1mR and FoxABS2mF
for Bra598FoxBS1,2m), as described above for making Bra598Ets1,2,3m.
Mutated nucleotides are underlined.
EtsBS1mF: gggctcgagTATTAACAATTTGTCATGCT
EtsBS2mR: GATGACTTCGAGCTAGTCTGAGCATGACAA
EtsBS3mF: TCACGTTTAATGCGTTTATCGAGACGAAAT
ZicBSmF: ATTCGAACTGAGCCCGATT
ZicBSmR: TATGAGAGGGATATCCCGCA
FoxABS1mR: TTATTATGTTTCTATGTATGGGCCATCAGTGCAATTG-
ATTGTCTC
FoxABS2mF: CAAATGCAGACAATCTAAAAATGGCCGAATATTCTT-
GTGCTTGCG
In order to make the constructs BraEtsBS2,3×3, BraZicBS×3, and
EtsBS2,3+ZicBS, short DNA oligomers containing tandemly repeated Ets
and/or Zic binding sites were inserted into the XhoI and NheI sites of the
construct Bra897Δ300–66. The region between −897 and −300 was removed
from the Bra897Δ300–66 construct by digestion with XhoI and NheI. Short
DNA oligomers were prepared by denaturing and annealing forward (F) and
reverse (R) oligonucleotides shown below for 30 min at 50 °C. Added sites for
NheI and XhoI in the oligonucleotides are shown in lower case.BraEtsBS2,3×3F:tcgaGCTATCCGTCATCTCACGTTTCCTGCGCTATC-
CGTCATCTCACGTTTCCTGCGCTATCCGTCATCTCACGTTTCCTG
BraEtsBS2,3×3R:ctagCAGGAAACGTGAGATGACGGATAGCGCAGG-
AAACGTGAGATGACGGATAGCGCAGGAAACGTGAGATGACGGA-
TAGC
BraZicBS×3F:tcgaTCCCTCTCAGCAGGCGAACTTCCCTCTCAGCAG-
GCGAACTTCCCTCTCAGCAGGCGAACT
BraZicBS×3R:ctagAGTTCGCCTGCTGAGAGGGAAGTTCGCCTGCT-
GAGAGGGAAGTTCGCCTGCTGAGAGGGA
EtsBS2,3+ZicBSF:tcgaTAGCTATCCGTCATCTCACGTTTCCTGCGTT-
TATCGAGTCCCTCTCAGCAGGCGAACT
EtsBS2,3+ZicBSR:ctagAGTTCGCCTGCTGAGAGGGACTCGATAAAC-
GCAGGAAACGTGAGATGACGGATAGCTA
Morpholino oligonucleotides and synthetic mRNA
To suppress Hr-Bra function, we injected 100 pg of a 25-mer morpholino
oligonucleotide (MO; Gene Tools), 5′-TTGTAATTGACATAATTCCTTGTAC-
3′ which covers the first methionine codon, into fertilized eggs. Previously
described Hr-ZicN MO and Hr-FoxA MO were similarly injected (Kumano et
al., 2006). For over/misexpression, 300 pg of synthetic Hr-ZicN, Hr-FoxA and
Hr-FoxDa mRNA (Kumano et al., in press) was injected together with reporter
constructs.
Microinjection and in situ hybridization
Circular plasmids were dissolved in sterile water with 0.1% Fast Green and
injected to 1%–1.5% of egg volume before the first cleavage as described
previously (Hikosaka et al., 1994). Fertilized eggs were treated with seawater
containing 0.05% actinase E (Kaken Pharmaceutical Co., Ltd., Tokyo) for 5 min
to remove follicle cells, and the vitelline membranes were attached to a cover
slip. Circular plasmids were dissolved in sterile water with 0.1% Fast Green and
injected to 1%–1.5% of egg volume. Injected embryos were cultured until the
110-cell stage and fixed. To detect lacZ mRNA, whole-mount in situ
hybridization was carried out as described previously (Wada et al., 1995).
Recombinant proteins and electrophoretic mobility shift assay (EMSA)
For EMSA, GST fusion proteins were expressed in DH5alpha E. coli. cDNA
fragments encoding the DNA-binding domains of Hr-Ets, Hr-ZicN, and Hr-
FoxA were amplified by PCR. Primers used were as follows (added sequences
containing restriction enzyme sites are shown in lower case).
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Hr-EtsDBD-R: gggtcgacATCTCCGCTCATTTTGTCCT
Hr-ZicNDBD-F: tttggatccAAAGGTCTGACTTGCAAATG
Hr-ZicNDBD-R: gggtcgacTCCTCCGTCGCTTTCTACCT
Hr-FoxADBD-F: ccaggatccaccATGGGGATAAACAGAAGAACGGAAA-
AGACCT
Hr-FoxADBD-R: ccagtcgacATTTTTCACGTTTCCCTTTGGGCTTGCAT-
TTGA
The amplified fragments were digested with BamHI and SalI, and inserted
into the multi cloning site of the pGEX-4T-3 expression vector. Expression of
GST fusion proteins was induced by adding 0.1 mM IPTG to the culture at
30 °C, and the protein was purified with glutathione agarose beads. The
recombinant proteins were cleaved with thrombin to remove GST. DNA probes
were labeled using a Biotin 3′ End DNA Labeling Kit (Pierce). After 1-min
denaturing, complementary oligonucleotides were annealed at 50 °C for 30 min.
The sequences of labeled probes are shown in Figs. 4, 7, and 8. The recombinant
proteins (200 ng) and biotin-labeled double-stranded oligo nucleotides (30 fmol)
were incubated with binding buffer for 20 min at room temperature. The binding
buffer for Hr-ZicN was 10 mM Tris–HCl (pH 7.5), 50 mM KCl, 1 mM DTT,
2.5% glycerol, 5 mMMgCl2, 50 ng/μl poly(dA·dT), 0.05% NP-40, and 500 μM
ZnSO4. The binding buffers for Hr-Ets and Hr-FoxAwere the same as that used
for Hr-ZicN with the exception that ZnSO4 was not included, and for Hr-FoxA
the concentration of glycerol was increased to 20%. Unlabeled competitor DNA
was added to the reaction buffer in 100-fold or 500-fold excess. Samples were
electrophoresed in 6% polyacrylamide gel in TGE buffer (10 mM Tris–HCl pH
8.5, 0.4 M glycine, and 0.2 mM EDTA) and transferred to a nylon membrane.
Biotin-labeled nucleotides were detected using a LightShift Chemiluminescent
EMSA Kit (Pierce).
Results
Initial promoter activity depends on FGF, Zic, and FoxA but
not on autoregulation
To identify the regulatory elements that respond to the FGF
signal during the initial activation of Hr-Bra expression, we
used a LacZ reporter fused with the Hr-Bra 5′ upstream
sequence (Fig. 1). The reporter activity was detected at the 110-
cell stage (Figs. 2A, B) by in situ hybridization with a LacZ
probe. Since our recent study has suggested that Hr-ZicN and
Hr-FoxA cooperate with the FGF signal (Kumano et al., 2006),
we focused on Hr-Ets, a transcription factor activated by FGFFig. 2. Roles of various transcription factors in reporter expression. (A) Expression o
ten notochord precursor cells at the 110-cell stage. (B) The expression is suppressed
formation was affected in Bra knockdown embryos. (E–H) Reporter expression from
expression in 50.0% of Bra knockdown embryos. Without MO, 10/16 expressed the r
(G) Hr-ZicN MO-, or (H) Hr-FoxA MO-co-injected embryos. (I) Schematic diagrams
to the 110-cell stage. Scale bar, 200 μm.signaling, and the intrinsic transcription factors Hr-FoxA and
Hr-ZicN (Fig. 2I). At low injected plasmid DNA concentration
(2 ng/μl) a LacZ reporter construct including 897 bp upstream of
the transcription initiation site (Bra897, Fig. 1), drove LacZ
expression only in notochord precursor blastomeres in 62.5% of
cases (see Figs. 3C, D). The reporter expression was mosaic, as
DNA injected into fertilized eggs was not inherited by all
blastomeres.
To exclude the possibility that this reporter expression is
driven entirely by an autoregulation mechanism by which the
Brachyury protein binds to its own promoter (Takahashi et al.,
1999b), we examined the promoter activity in the absence of Hr-
Bra protein by injection of morpholino antisense oligonucleotide
(MO). Because Hr-Bra MO-injected embryos showed tail
defects, it is likely that Hr-Bra MO inhibits Hr-Bra function
(Figs. 2C, D). In such Brachyury-knockdown embryos, the
LacZ reporter from Bra897 (2 ng/μl) was still expressed in
notochord precursor blastomeres in 50.0% of embryos (Fig. 2E,
n=12), similar to results obtained without MO injection (62.5%,
Fig. 3). This indicates that autoregulation is not required for Hr-
Bra promoter activity to be detectable at the 110-cell stage,
although autoregulation could augment Hr-Bra expression
levels in untreated 110-cell embryos. Dispensability of auto-
regulation for initial expression was also confirmed by the
detectable expression at the 110-cell stage of Bra897, which
lacks a region containing the autoregulation site (Bra897Δ300/
66 in Figs. 6A, B). The reporter expression from Bra897 (2 ng/
μl) was suppressed in Hr-Ets-, Hr-ZicN-, and Hr-FoxA-knock-
down and MEK-inhibitor-treated embryos (Figs. 2F–H and 3H,
I). These results indicate that the 897 bpHr-Bra upstream region
contains elements that respond to the FGF signal, Zic and FoxA.
The −598/−499 region is essential for response to FGF signal
We prepared a 5′-deletion series of Hr-Bra promoter
constructs (Fig. 3A) and injected them into fertilized eggs at
2 ng/μl. Bra897, Bra798, Bra698, and Bra598 drove reporter
expression in notochord precursor cells in 62.5%, 39.1%,f endogenous Hr-Bra was detected by in situ hybridization. Bra is expressed in
by MEK inhibitor treatment. (C) Control embryos at the tailbud stage. (D) Tail
Bra897 in the absence of various transcription factors. (E) Bra897 drives lacZ
eporter (Fig. 3). (F–H) Bra promoter activity was suppressed in (F) Hr-Ets MO-,
showing expression patterns of Hr-Bra, Hr-ZicN, and Hr-FoxA from the 16-cell
Fig. 3. 5′-Deletion analysis of Hr-Bra promoter at low concentration (2 ng/μl). (A) Schematic drawing of 5′-deletion constructs. (B) Vegetal view of the embryo at the
110-cell stage. Notochord precursor blastomeres are indicated in pink. (C–G) lacZ mRNAwas detected at the 110-cell stage by in situ hybridization. (C) Percentages
of reporter-positive embryos that show notochord-specific reporter expression. (D, E) Reporter-positive embryos injected with Bra897 (D) or Bra598 (E). The lacZ
reporter is specifically expressed in notochord, although the expression is mosaic and is not observed in every notochord precursor. (F) Bra499- and (G) Bra398-
injected embryos. The signal is absent. (H–L) Embryos were treated with MEK inhibitor and the reporter signal was suppressed in embryos injected with any of the
constructs shown here. Scale bar, 200 μm.
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contrast expression from Bra499 and Bra398 was barely
detectable (Figs. 3C, F, G). To evaluate the role of FGF
signaling, we further analyzed these 5′-deletion series in MEK-
inhibitor-treated embryos. Promoter activity was suppressed
when FGF signaling was inhibited, although Bra698 and
Bra398 occasionally gave weak activity (Figs. 3H–L). These
results suggest that reporter expression driven by the constructs
examined here recapitulates endogenous Hr-Bra expression in
terms of its specific expression in notochord and its sensitivity to
FGF signaling, and that the −598/−499 region has elements that
are required for the initial Hr-Bra expression.
Hr-Ets protein binds to the −598/−499 region and activates
Hr-Bra transcription
In notochord induction, the FGF signal is transduced to
activate the Hr-Ets transcription factor protein (Miya and
Nishida, 2003). Hr-Bra promoter activity also requires Hr-Ets
function (Fig. 2F). Therefore, we searched for conserved core
binding sequences of Ets transcription factors (GGAA/T or
complementary) in the upstream 897-bp region. Within the
−598/−499 region, three putative binding sites, which we
designated EtsBS1 (−596/−593), EtsBS2 (−568/−565), and
EtsBS3 (−552/−549) were found (Fig. 1). In addition, we found
several candidate sites outside of the region. To determinewhether Ets protein directly binds to these putative EtsBSs, we
carried out electrophoretic mobility shift assay (EMSA).
Recombinant protein consisting of a Hr-Ets DNA-binding
domain (Hr-EtsDBD) was used in this binding assay with
oligonucleotides corresponding to each putative EtsBS (Fig. 4).
Purified recombinant Hr-EtsDBD bound to EtsBS2 and EtsBS3,
but only faintly to EtsBS1 (Fig. 4C, lanes 1, 4, 7). The
specificity of the binding was confirmed by the use of mutated
oligonucleotides (lanes 2, 5, 8) and by addition of unlabeled
competitors (lanes 3, 6, 9). These results indicate that Hr-
EtsDBD specifically binds to EtsBS1, EtsBS2, and EtsBS3. No
shifted band was observed for other candidate sites (lanes 10–
15) outside the −598/−499 region.
To investigate the role of EtsBS1, EtsBS2, and EtsBS3 in
initial expression of Hr-Bra promoter activity, we introduced
mutations at all three binding sites (Bra598EtsBS1,2,3m).
Bra598EtsBS1,2,3m (2 ng/μl) was expressed only in 9.0% of
injected embryos (n=22, Fig. 9A), which is significantly lower
than non-mutatedBra598 (59.0%, Fig. 3C). These results suggest
that Ets activates Hr-Bra expression by binding to these EtsBSs,
and these binding sites constitute an FGF-responsive element.
Presence of other enhancer elements in the −499/−289 region
When 10 times the concentration (20 ng/μl) of reporter DNA
was injected, different results were obtained. The frequency of
Fig. 4. Hr-Ets protein binds to the Hr-Bra promoter. (A) Schematic drawing of
Hr-Ets. The black box indicates the Hr-Ets DNA-binding domain (DBD). A
purified recombinant DBD protein was used in the binding assay. A pointed
domain, which is located near the MAPK phosphorylation site and binds to
MAPK in other organisms (Brunner et al., 1994; Wasylyk et al., 1997), is
conserved in Hr-Ets. (B) Probe sequences used in binding assay (Fig. 1, red
underlines). Core binding sequences for Ets (GGAA/T or complementary) are
shown in red. Underlined lower case letters indicate the mutated nucleotides. (C)
Electrophoretic mobility shift assay. Arrowhead indicates shifted bands (lanes 1,
4, 7). The binding activities were absent with either mutant probes (lanes 2, 5, 8)
or 100× excess unlabeled competitor (lanes 3, 6, 9). No binding activity was
detected with other probes (lanes 10–15).
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intensity of the reporter expression became higher. However,
reporter was expressed in the nerve cord (purple in Fig. 5) and
endoderm precursor (yellow) cells in addition to notochord. It
seems that the ectopic reporter expression is not random,
because the ectopic signal was restricted only to the nerve cord
and endoderm precursor cells. Zic and FoxA are good candidate
factors responsible for ectopic expression, because endogenous
expression patterns of these genes overlap domains of ectopic
expression: Zic is expressed in notochord and nerve cord, and
FoxA in notochord and endoderm (Fig. 2I; Shimauchi et al.,
1997; Wada and Saiga, 2002). The biggest difference between
injecting high and low doses is that while Bra499 and Bra398,
which lack the three Ets-binding sites, did not drive reporter
expression at low concentration, they did at high concentration
(Figs. 5A–D). Since the reporter expression driven by Bra398
in endoderm precursor cells was reduced (8.6%, n=23, Fig.
5A) compared to that driven by Bra499 (58.3%, n=24, Fig.
5A), the −499/−398 region could contain an enhancer element
that promotes ectopic endoderm expression. Likewise, since
Bra289 and Bra198 did not drive the reporter even at high
concentration, the −398/−289 region could have another
enhancer element.When embryos injected with the same reporter constructs
were treated with MEK inhibitor, reporter expression was not
eliminated (Figs. 5F–I). Thus, the reporter expression at high
concentration is independent of the FGF signal and does not
recapitulate endogenous Hr-Bra expression. This is consistent
with the fact that Bra499 and Bra398, lacking the three Ets-
binding sites, still drive reporter expression at high concentra-
tion. Promoter activity at high concentration may reveal
intrinsic capabilities for ectopic expression that are normally
repressed.
To further examine the regulatory region of the Hr-Bra
promoter, we prepared a 3′-deletion series (Fig. 6A). This
proximal deletion series does not have the enhancer element and
autoregulation region previously identified (−280/−250 and
−170/−150, respectively; Takahashi et al., 1999a). Bra897Δ300/
66 and Bra897Δ400/66 at high concentration (20 ng/μl) drove
lacZ expression in notochord precursor cells at 90.3% (n=52)
and 21.7% (n=23), respectively (Figs. 6B–D). Since shorter
constructs did not drive the expression at high concentration
(20 ng/μl) (Figs. 6B, E), these results suggest that the −400/
−300 region has a strong enhancer activity. This coincides with
results of the 5′ deletion series, which showed that the −398/
−297 region could have an enhancer element. The sole FGF-
responsive element identified above (the −598/−499 region) is
not enough to drive reporter expression without the −500/−300
region, as seen in the activity of the construct Bra897Δ500/66
(Figs. 6A, B, E).
Hr-ZicN binds to Hr-Bra promoter and activates its
transcription
Zic superfamily transcription factors such as Zic, Opa, Gli,
and macho-1 recognize and bind to GC-rich sequences in
DNA (Aruga, 2004; Aruga et al., 1994; Kinzler and
Vogelstein, 1990; Mizugishi et al., 2001). In ascidians,
previous studies on the Zic superfamily by SELEX have
also shown that there are GC-rich sequences in the binding
sites for Ci-ZicL, Ci-macho-1, and Hr-macho-1 (Table 1)
(Yagi et al., 2004a,b; Sawada et al., 2005). Therefore, we
performed EMSA with six GC-rich sequences that we found
in the Hr-Bra promoter including two sequences within the
−398/−289 region. A recombinant protein consisting of a
zinc-finger domain of Hr-ZicN (Hr-ZicNDBD) was used (Fig.
7A). Hr-ZicNDBD bound only to the B333-314 probe (Figs.
7B, C, lane 3). The specificity of the binding was confirmed
by the addition of unlabeled competitor (lane 4). A mutant
probe in which four of the Gs and Cs in the GC-rich
sequence were replaced by Ts and As (B333-314m2) did not
bind (lane 6), whereas the 5′-end mutant (B333-314m1) did
(lane 5). Therefore, we regarded the central GC-rich region of
the B333-314 probe as a Zic binding site (ZicBS) (Fig. 1). The
B150-131 and B127-108 probes gave faint shifted bands (lanes 8
and 11, open arrowhead). This is probably non-specific binding,
because these bands did not disappear with the addition of a 500-
fold excess of competitor (lanes 9, 12).
We next performed reporter analysis by introducing a
mutation in the ZicBS of Bra598 (Bra598ZicBSm) and injecting
Fig. 5. 5′-Deletion analysis of Hr-Bra promoter at high concentration (20 ng/μl). (A–E) The reporter signal is strong in notochord (pink) precursors, but is also
ectopically detected in nerve cord (purple) and endoderm (yellow) precursors. The position of each precursor at the 110-cell stage is shown in the diagram to the right.
(A) Percentages of reporter-positive embryos that show expression in each lineage. (B–E) Bra798 (B), Bra499 (C), Bra398 (D) or Bra289 (E) was injected. (F–J)
Embryos were treated with MEK inhibitor. The reporter expression seen with Bra398 or longer constructs is insensitive to MEK inhibitor. Note that autoregulation is
completely absent in these MEK-inhibitor-treated embryos, because the endogenous Hr-Bra is absent without an FGF signal. Scale bar, 200 μm.
876 J. Matsumoto et al. / Developmental Biology 306 (2007) 870–882the construct at low concentration (2 ng/μl). Reporter expression
driven by Bra598ZicBSm was seen in only 22.5% of injected
embryos (n=31) (Fig. 9B), compared with 59.0% for non-
mutated Bra598 (Fig. 3E). To further examine the effect of ZicFig. 6. Proximal deletion series injected at high concentration (20 ng/μl). (A) Schemat
indicate the three EtsBSs. (B–E) LacZ reporter expression promoted by each constr
drove the reporter expression in 90.3% and 21.7%, respectively, of the embryos that
Bra897Δ600/66, Bra897Δ700/66, and Bra897Δ800/66) did not drive detectable repon Hr-Bra promoter activity, we co-injected ZicN mRNA into
eggs. Bra398 at high concentration with the RNA drove strong
reporter expression in the lateral half of the embryos (Fig. 9G)
(injected mRNA does not diffuse throughout the embryo butic drawing of proximal deletion constructs of Hr-Bra promoter. Small open boxes
uct was detected by in situ hybridization. Bra897Δ300/66 and Bra897Δ400/66
had been injected with the constructs. The shorter constructs (Bra897Δ500/66,
orter gene expression. Scale bar, 200 μm.
Table 1
List of zinc finger and FoxA transcription factor binding sequences
Nomination Required sequence for binding Reference
Gli binding sequence 5′-TGGGTGGTC-3′ Kinzler and Vogelstein, 1990
Aruga et al., 1994
Optimized zic binding sequence GGGTGGTC Mizugishi et al., 2001
Ci-ZicL binding sequence (ZicL-b) CACAGCGGG Yagi et al., 2004b
Ci-ZicL binding site of Ci-Bra promoter (Bra-168,123) CACAGCTGG Yagi et al., 2004b
Ci-ZicL binding site of Ci-Bra promoter (Bra-731) GACTGCTGG Yagi et al., 2004b
Ci-macho-1 binding sequence (macho-1-b) CAGCGGGGGGC Yagi et al., 2004a
Hr-macho-1 binding sequence TKGGKGGTC Sawada et al., 2005
Hr-ZicN binding site of Hr-Bra promoter (Bra-327) CTCAGCAGG Present study
FoxA binding consensus sequence 5′-VAWTRTTKRYTY-3′ Overdier et al., 1994
FoxA binding sequence HNF3#4 TAATGTTTGTTT Overdier et al., 1994
FoxA binding site of TTR promoter GATTATTGACTT Ruminy et al., 2001
FoxA binding site of AMBP promoter (−2744) TCTGTTTGCTC Ruminy et al., 2001
FoxA binding site of AHSG promoter (−2505) TTTTTTGTTTGTTT Ruminy et al., 2001
Hr-FoxA binding site of Hr-Bra promoter (−411) TATGTTTGTTC Present study
Hr-FoxA binding site of Hr-Bra promoter (−369) TTCTTTGCTT Present study
K=T/G, Y=C/T, W=A/T, R=G/A, V=A/C/G.
877J. Matsumoto et al. / Developmental Biology 306 (2007) 870–882tends to be partitioned into a single blastomere at the first
cleavage). Thus, Zic directly activates Hr-Bra promoter by
binding to the ZicBS.Fig. 7. EMSA analysis of Hr-ZicN-binding activity. (A) Schematic drawing of
Hr-ZicN protein. Black box indicates zinc finger DNA-binding domain. A
purified recombinant Hr-ZicNDBD was used in the binding assay. (B) Probes
that contain GC-rich sequences found in the Bra promoter region (Fig. 1, red
underlines). Underlined lower case letters indicate the mutated nucleotides. Red
nucleotides indicate Gs and Cs important for ZicN binding. (C) EMSA. Black
arrowhead indicates shifted bands (lanes 3, 5). Binding with B333-314 was
decreased by addition of 500× excess unlabeled competitor (lane 4) and negated
by the mutation of red GC sequences (B333-314m2, lane 6). There was no
specific binding with other probes (lanes 1, 2, 7–13). Open arrowhead indicates
nonspecific band observed when B150-131 and B127-108 were used.Role of Hr-FoxA
We have previously shown that both Hr-FoxA and Hr-
ZicN are required as intrinsic competence factors for
notochord induction (Kumano et al., 2006). Two candidates
for Fox-binding sites, FoxBS1 (−411/−402) and FoxBS2
(−363/−354) (Table 1, Fig. 8B), were identified by sequence
homology to previously identified Fox-binding sites in other
genes/animals (Overdier et al., 1994; Ruminy et al., 2001).
First, we performed EMSA with B415-396 (FoxBS1) and
B369-350 (FoxBS2) probes (Fig. 1 red underlines, and Fig.
8). Both probes gave faint shifted bands, and the addition of
competitors confirmed the specificity (Fig. 8C). However, the
binding of FoxA to these probes was very weak.
We examined the importance of FoxBS1 and FoxBS2 by
reporter analysis with a construct in which both were mutatedFig. 8. EMSA analysis of Hr-FoxA-binding activity. (A) Schematic drawing
of Hr-FoxA protein. Black box indicates a conserved forkhead DNA-
binding domain. A purified recombinant forkhead DNA-binding domain
was used in the binding assay. (B) Probes of putative FoxA-binding sites
in the Hr-Bra promoter (Fig. 1, red underlines). The red nucleotides
indicate conserved sequences of FoxA-binding sites. (C) EMSA. Only
weak shifted bands were observed with B415-396 (FoxBS1) and B369-349
(FoxBS2) (lanes 1, 3, arrowhead). These shifted bands were lost when a
100× excess of unlabeled competitor oligonucleotide was added during
DNA binding (lanes 2, 4).
878 J. Matsumoto et al. / Developmental Biology 306 (2007) 870–882(Bra598FoxBS1,2m). However, the reporter was expressed in
64% of embryos (n=14) at low concentration (Fig. 9C). There
was no significant difference in the frequency of reporter-
positive embryos between Bra598FoxBS1,2m and Bra598.
However, while we never saw ectopic expression in nerve cord
with Bra598 (Fig. 3E), injection of Bra598FoxBS1,2m resulted
in ectopic expression in nerve cord in 22% of cases (Fig. 9C,
arrowheads).
To further characterize the role of FoxA inHr-Bra activation,
we overexpressed FoxA. In this experiment, to evaluate FoxA
function independent of Zic, we co-injected Zic MO with FoxA
mRNA to avoid the influence of Zic, because FoxA activates
the transcription of Zic (Kumano et al., 2006). A high dose of
Bra398 promoted reporter expression in 35.2% (n=17) of
embryos when FoxA mRNA/Zic MO was co-injected, and
ectopic expression was observed in the animal hemisphere (Fig.
9H, arrowheads), which was never observed without FoxA
mRNA injection. However, the signal was faint and the effect
was not as dramatic as in Zic-overexpressing embryos (Fig.
9H). Thus, these FoxBSs appear to be less important for Hr-Bra
enhancer activity than the EtsBs and ZicBS are. It is, however,
possible that FoxA could act through yet unidentified FoxBSs,Fig. 9. Characterization of transcription factor binding sites. (A–C) Constructs with
constructs are shown under each photo. Crosses indicate mutated binding sites. (A, B)
embryos. (C) Mutation of FoxBSs did not decrease the frequency of positive embry
(arrowhead). (D–F) The constructs containing EtsBS, ZicBS, or both, as shown below
did not drive reporter expression. (E) BraZicBS×3 drove ectopic reporter expressio
40.9% of cases. (G, H) Overexpression of Hr-ZicN and Hr-FoxA activates the Hr-
mRNAwas frequently partitioned into one bilateral half of the embryo. (H) Bra398 r
reporter signals in animal blastomeres. Scale bar, 200 μm.and FoxA may be necessary but not sufficient for the promoter
activation of brachyury gene.
Insufficiency of EtsBS and ZicBS for initial expression of
Hr-Bra
In an analysis of Ci-Otx enhancer, Bertrand et al. (2003)
found that a simple tandem repeat of Ets- and GATA-binding
sites is enough to promote reporter expression in the anterior
neural lineage cells. We carried out similar experiments with
EtsBS and ZicBS ofHr-Bra. The capability of EtsBS and ZicBS
was further analyzed using reporter constructs that contained
repeated or inter-laced binding sites fused to the Bra66 basal
promoter. A construct with three repeats of EtsBS2 and 3
(BraEtsBS2,3×3) did not drive reporter expression even when
injected at high concentration (Fig. 9D). Likewise, a construct
containing three repeats of ZicBS (BraZicBS×3) drove faint ex-
pression ectopically in epidermis in 13.3% of embryos (Fig. 9E).
Finally, the combination of EtsBS2,3 and ZicBS (BraEtsBS2,
3+ZicBS) gave ectopic reporter expression in epidermis in
40.9% of cases (Fig. 9F). These results suggest that although
EtsBS and ZicBS are required for initial expression of Hr-Bra,EtsBSs (A), ZicBS (B), or FoxBS (C) mutated were injected at 2 ng/μl. Injected
Mutation of either EtsBSs or ZicBS decreased the frequency of reporter-positive
os. 21.7% of embryos had ectopic reporter signals in the nerve cord precursors
each photo, were injected at high concentration (20 ng/μl). (D) BraEtsBS2,3×3
n only weakly. (F) BraEtsBS2,3+ZicBS drove ectopic reporter in epidermis in
Bra promoter. (G) Bra398 reporter was co-injected with Zic mRNA. Injected
eporter was co-injected with FoxAmRNA and Zic MO. Arrowheads indicate the
879J. Matsumoto et al. / Developmental Biology 306 (2007) 870–882they are unlikely to be sufficient to support notochord-specific
expression.
Discussion
Takahashi et al. (1999b) identified the enhancer (−290/
−250) and autoregulation (−170/−150) regions in Hr-Bra
promoter analysis by looking at reporter expression at the
tailbud stage with the aid of β-galactosidase enzyme activity.
Here, we analyzed an enhancer region (−897/−66) that is
involved in the initial expression of Hr-Bra at the 110-cell
stage, by in situ hybridization of LacZ mRNA just after the
initiation of Hr-Bra expression at the 64-cell stage. Neither of
the previously identified regions was required for reporter
expression at the 110-cell stage. Therefore, the enhancer (−290/
−250) and autoregulation regions might contribute to main-
tenance after initial gene activation. The study of mechanisms
by which Brachyury gene expression is initially activated will
be important to uncover fate specification mechanisms of
notochord precursor cells. In this study, we showed that binding
sites for Hr-Ets and Hr-ZicN are present in the 5′ upstream
region of the Hr-Bra promoter region, and are required for
FGF-responsive Hr-Bra gene activation in notochord precursor
cells. The results suggest that the extracellular FGF signal and
the intrinsic state of signal-receiving cells are integrated at the
level of a notochord-specific enhancer and are required for the
initial expression of Hr-Bra, a key transcription factor for
notochord differentiation.
The FGF-responsive element
We have shown that Hr-Ets directly regulates notochord-
specific Hr-Bra promoter activity, and that the three EtsBSsFig. 10. Comparison of the regulatory elements in the Hr-Bra and Ci-Bra promote
indicate the enhancer and T-BoxBS, respectively, which constitutes the ‘notochord ac
activates its own transcription via T-BoxBS (arrow). Two independent ectopic activ
region promoted ectopic expression in nerve cord (Fig. 5). Likewise, the −499 to −3
promoted ectopic expression in endoderm (Fig. 5). The −499 to −398 region migh
responsive element (−598 to −499) was also identified (Fig. 3) and was found to have
text also). (B) Regulatory elements of the Ci-Bra promoter. The promoter region can
region (−299 to −188) contains two Su(H)-binding sites (black boxes). The ectopic a
lineages. Ectopic activation in notochord sister lineages is repressed by the ectopic re
Ci-Sna-binding sites (white ellipses) (Fujiwara et al., 1998). Two ZicBSs have beenidentified in the region between −598 and −499 constitute a
plausible FGF-responsive element. Why is Hr-Bra not ex-
pressed in every Ets-activated blastomere, despite the fact that
Ets is thought to be active not only in the notochord lineage, but
also in cells of other lineages? FGF9/16/20, which is
responsible for Ets activation, is expressed in most blastomeres
in the vegetal hemisphere (Imai et al., 2002a; Kumano et al.,
2006). In fact, FGF-responsive MAPK is activated in various
tissue precursor blastomeres (Nishida, 2003). In addition, Ets is
required for the formation of mesenchyme and brain as well as
notochord (Miya and Nishida, 2003). Generally, Ets transcrip-
tion factors interact with co-regulatory partners to elicit gene-
specific responses (Sharrocks, 2001). Recent studies have
unveiled intrinsic factors involved in mesenchyme, brain, and
notochord induction in ascidian embryos. Posteriorly localized
macho-1 transcription factor cooperates with Ets to promote
mesenchyme fate (Kobayashi et al., 2003). GATA transcription
factor in the animal hemisphere together with Ets was required
for otx expression in brain lineage (Bertrand et al., 2003).
Zygotically expressed FoxA and Zic transcription factors have
been proposed to be intrinsic factors in notochord induction
(Kumano et al., 2006). We found in this study that the initial
expression of Hr-Bra is controlled by complex mechanisms that
involve extrinsic FGF signaling and intrinsic competence
factors. Bra897Δ500/66, which carries multiple Ets-binding
sites but lacks other regions, including the site to which Hr-
ZicN binds, was insufficient to promote expression. Therefore,
Ets and Zic might form a notochord-specific partnership.
Alternatively, Ets might interact with Zic via CREB-binding
protein (CBP). There are putative CREB-binding sites next to
EtsBSs (Figs. 1 and 10). Since CBP and Ets interact with each
other (Foulds et al., 2004), it is possible that CREB, CBP, and
Ets form a complex and activate the Hr-Bra transcription. Zicrs. (A) Regulatory elements of the Hr-Bra promoter. Shaded and black boxes
tivation at late stages’ region (−300 to −66) (Takahashi et al., 1999b). Brachyury
ation domains were identified. The −398 to −300 region plus the −300 to −66
98 region plus the ‘notochord and nerve cord activation’ region (−398 to −66)
t also serve as a repressor domain for ectopic nerve cord expression. The FGF-
three Ets-binding sites (white boxes) and a CREB-binding site (white ellipse; see
be subdivided into three regions (Corbo et al., 1997). The notochord activation
ctivation region (−188 to −22) has enhancer activity in notochord and its sister
pression region (−434 to −299). Ci-Sna represses ectopic muscle activation via
identified in the ectopic activation region (black ellipses) (Yagi et al., 2004b).
880 J. Matsumoto et al. / Developmental Biology 306 (2007) 870–882and FoxA could interact with CBP, because CBP is a large
molecule that is capable of interacting with numerous partners.
Differences in reporter gene expression between low and high
construct DNA concentration
At low DNA concentration (2 ng/μl), the reporter expression
promoted by the constructs containing a promoter region of
598 bp or longer recapitulated normal notochord-specific Hr-
Bra gene expression and showed dependence on the FGF signal
and on Hr-ZicN and Hr-FoxA. This permitted us to identify the
FGF-responsive element. At high concentration (20 ng/μl), on
the other hand, the reporter expression did not recapitulate the
endogenous Hr-Bra expression. Instead, ectopic expression
was observed in nerve cord and endoderm precursors in
addition to notochord, even when FGF signaling was blocked.
However, this analysis using a high dose of the constructs was
still useful and, in fact, with this approach we identified the
−398/−300 region as a strong enhancer element that contains
ZicBS. In general, the amount of reporter DNA used for
transient reporter expression analysis in ascidian embryos
should be carefully assessed. The range of reporter DNA
concentrations that faithfully recapitulate endogenous gene
expression patterns could be narrow. Perhaps normal regulation
requires the simultaneous binding to individual DNA molecules
of multiple factors including FGF responsive and FGF-
independent stimulatory factors and inhibitory factors. At
high DNA concentrations, one or more such factors may
become limiting, so that some DNA molecules will contain an
incomplete subset of the normal complement of factors, which
could give rise to misregulated expression.
The role of ZicBS
The −398/−300 region has strong enhancer activity, and
ZicBS is present in the region. ZicBS is likely to account for the
ectopic reporter expression in the notochord sister lineage nerve
cord when the constructs are injected at high concentration, since
Zic is normally expressed in nerve cord precursors in addition to
notochord precursor (Wada and Saiga, 2002; Fig. 2I).
The frequency of reporter expression was decreased in the
ZicBS-mutated reporter construct. Also, co-expression of Hr-
ZicN resulted in broad reporter expression from Bra398, as is
observed in Ciona (Yagi et al., 2004b). In addition, our gel-shift
analysis showed that Hr-ZicN indeed binds to the ZicBS. These
results indicate that Zic activates Hr-Bra transcription by direct
binding to the promoter. In contrast, overexpression of Hr-ZicN
results in repression of endogenous Hr-Bra gene expression
(Wada and Saiga, 2002). This seems inconsistent with our
results. A possible explanation for this discrepancy is that
presumptive notochord precursor cells might have assumed
nerve cord fate in Zic mRNA-injected embryos. In these
embryos, Zic mRNA was injected just after fertilization, and
therefore notochord cannot be immediately induced, because
other factors, such as FGF, are not yet available. In normal
embryos, Zic-expressing blastomeres assume nerve cord fate
without FGF signaling. Therefore, cells in Zic mRNA-injectedembryos might have precociously assumed nerve cord fate. In
fact, broad expression of a neural plate marker, ETR-1, was
observed in Zic mRNA-injected embryos (Wada and Saiga,
2002). On the other hand, in embryos into which excess reporter
was introduced, the reporter simply responded to overexpressed
Zic mRNA and drove LacZ expression.
Role of putative FoxBSs
Our results indicate that ZicBS and/or EtsBS are not
sufficient to drive notochord-specific expression, although we
did not examine the effects of the number of binding sites and
the space between binding sites. This contrasts with the case of
Ci-Otx enhancer, in which a simple tandem repeat of Ets-
binding sites and GATA-binding sites is able to promote reporter
expression in anterior neural lineage cells (Bertrand et al.,
2003). Another important candidate factor is FoxA. Hr-FoxA
has been proposed as an intrinsic factor in addition to Zic in
notochord induction (Kumano et al., 2006). FoxA can promote
ectopic expression of endogenous Hr-Bra even in the animal
hemisphere. Hr-ZicN is downstream of Hr-FoxA. However,
Hr-ZicN overexpression alone does not cause ectopic expres-
sion of Hr-Bra. Therefore, Hr-FoxA and Hr-ZicN have been
assigned as intrinsic competence factors for notochord induc-
tion. Our recent data further support the role of Hr-FoxA
independent of Hr-ZicN (Kim et al., 2007). The importance of
FoxA in Brachyury expression is also supported in Ciona (Imai
et al., 2006). We suppose that FoxA is responsible for the
ectopic endoderm expression observed when reporter constructs
are injected at high concentration, as FoxA is normally
expressed in notochord and endoderm (Shimauchi et al.,
1997; Fig. 2I).
The Hr-Bra promoter in fact contains two putative FoxBSs
around −400. In particular, FoxBS1 (TATGTTTGTTC) shows
an almost perfect match with the FoxA-binding consensus
sequence (Table 1). However, it is not clear whether these
FoxBSs represent functional FoxA-binding sites. Reporter
expression was lost when FoxA MO was co-injected, but
probably Hr-ZicN expression was also eliminated in those
embryos. EMSA with Hr-FoxADBD and the probes corre-
sponding to these sites gave too-faint bands to allow us to
conclude that Hr-FoxA binds to the probes, although there is a
possibility that the binding buffer used for EMSA was not
optimized for ascidian FoxA protein. Mutation of these two
sites did not affect reporter expression.Hr-FoxA overexpression
did cause weak ectopic expression in the animal hemisphere,
but this was too weak to be entirely convincing. Indirect
evidence to support the idea is that ectopic expression of
Bra398, in which FoxBS1 is removed, in endoderm was
significantly reduced (Fig. 5A). In addition, when we removed
the FoxBS2 site from the Bra398 reporter, the reporter lost its
activity even when injected at high concentration (data not
shown). Therefore, Hr-FoxA might bind to these sites, but plays
rather a minor role in reporter expression promoted by Bra897,
compared to the major role played by Hr-Zic as suggested
above. Hr-FoxA may regulate the Hr-Bra promoter directly or
indirectly through its downstream transcription factors. It is also
881J. Matsumoto et al. / Developmental Biology 306 (2007) 870–882possible that Hr-FoxA acts not as an activator but as a releaser
of repression, because FoxA is required for the establishment of
competence in liver-specific gene expression by opening up
condensed chromatin and allowing transcription factors to
access to the enhancer (Lee et al., 2005).
There are different possibilities as to how these FoxBSs
might function. One possibility is that FoxD represses Bra-
chyury expression via the FoxBSs in endoderm precursors.
FoxD3 is a transcription repressor in Xenopus (Pohl and
Knochel, 2001; Sullivan et al., 2001). Ascidian FoxD is ex-
pressed in endoderm/notochord precursors at the 16-cell stage,
but is downregulated only in notochord precursors at the 32-cell
stage (Imai et al., 2002c; Kumano et al., 2006). Overexpression
of FoxD resulted in elimination of expression of both
endogenous Bra (Kumano et al., 2006) and the reporter
expression of Bra897 (20 ng/μl) (data not shown).
FoxB, on the other hand, might repress Brachyury expression
in nerve cord precursors via the FoxBSs. FoxB is first expressed
in the nerve cord precursors at the 44-cell stage right after the cell
division that divides notochord/nerve cord mother cells to
produce notochord and nerve cord precursors (Imai et al., 2006).
In high concentration reporter analysis Bra398, which lacks
FoxBS1, was expressed in nerve cord precursors at higher
frequency (Figs. 5A, D). This is further supported by the fact that
reporter expression promoted by Bra598FoxBS1,2m was
observed in the nerve cord (Fig. 9C), but was never seen when
Bra598 was injected. Together, these results imply that FoxBSs
in the Brachyury promoter could be binding sites for FoxD or B.
Moreover, a further interesting possibility is that FoxA, D, and B
could compete for the same FoxBSs to activate or suppress
Brachyury expression.
Comparison of Brachyury promoters between Halocynthia and
Ciona
In comparative analysis of Hr-Bra and Ci-Bra promoters
both showed cross-species compatibility (Takahashi et al.,
1999b), although activity was studied only at tailbud stage.
Despite the compatibility, however, a conserved sequence has
not been found in these promoter sequences. Fig. 10 shows
similarities and differences. Ectopic activation and repression
elements are present in both promoters. ZicBSs exist in the
ectopic activation regions and account for reporter expression
in notochord and ectopic expression in nerve cord. It is possible
that FoxB represses ectopic activation in the nerve cord
precursors. The Ci-Bra promoter would likely have an EtsBS,
because the FGF signaling pathway is also required for early
expression of Ci-Bra (Imai et al., 2002a). In Ciona, the −434/
−299 region has been assigned as being responsible for the
repression of ectopic muscle and nerve cord expression. Snail
is expressed in muscle/mesenchyme precursors at the 32- and
64-cell stages. Ci-Sna represses the ectopic reporter expression
in muscle by direct binding to the Ci-Bra promoter (Corbo et
al., 1997; Fujiwara et al., 1998). There may be Snail-binding
sites in the Halocynthia promoter, because overexpression of
Hr-Sna results in the repression of Hr-Bra (Kobayashi et al.,
2003). Thus, as already reported in Hr-Otx and Ci-Otxpromoter comparison analysis (Oda-Ishii et al., 2005), no
long-range similarity in the primary sequences is recognizable
in the Brachyury promoter regions of the two species, but short
binding motifs (for example ZicBS) may be conserved.
The −299/−188 region in the Ci-Bra promoter region
contains two Su(H)-binding motifs. This region is primarily
associated with Ci-Bra expression in secondary B-line
notochord cells (Yagi et al., 2004b). Notch signaling is
involved in secondary notochord formation in Ciona (Imai et
al., 2002c; Hudson and Yasuo, 2006), but not in Halocynthia
(unpublished data). Therefore, Su(H)-binding sites are likely
not present in Halocynthia, and none is evident in the Hr-Bra
promoter sequence.
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